Detalles de la búsqueda
1.
Multimode Sensing Platform Based on Turn-On Fluorescent Silicon Nanoparticles for Monitoring of Intracellular pH and GSH.
Anal Chem
; 95(16): 6664-6671, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036832
2.
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-ß/Smad pathway suppression in hepatic stellate cells.
Biochem Biophys Res Commun
; 642: 192-200, 2023 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36586187
3.
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.
Lab Invest
; 102(10): 1150-1157, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643859
4.
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.
Int J Mol Sci
; 23(19)2022 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36233317
5.
Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells.
Biochem Biophys Res Commun
; 549: 171-178, 2021 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676186
6.
Mitochondria-Targeted Thymidylate Synthase Inhibitor Based on Fluorescent Molecularly Imprinted Polymers for Tumor Antimetabolic Therapy.
ACS Appl Mater Interfaces
; 15(26): 31139-31149, 2023 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37353471
7.
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma.
World J Virol
; 12(3): 209-220, 2023 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37396703
8.
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma.
Int Immunopharmacol
; 118: 110068, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001386
9.
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Anticancer Res
; 43(3): 1043-1052, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854524
10.
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
J Cancer
; 13(8): 2656-2661, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711837
11.
Targeted Mitochondrial Fluorescence Imaging-Guided Tumor Antimetabolic Therapy with the Imprinted Polymer Nanomedicine Capable of Specifically Recognizing Dihydrofolate Reductase.
ACS Appl Mater Interfaces
; 13(34): 40332-40341, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34412467
12.
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma.
J Cancer
; 12(9): 2694-2701, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854629
13.
Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
ACS Appl Mater Interfaces
; 12(22): 24585-24598, 2020 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32390415
Resultados
1 -
13
de 13
1
Próxima >
>>